Stockreport

Adaptimmune Therapeutics PLC Reports Q4 and Full Year 2023 Financial Results [Yahoo! Finance]

Adaptimmune Therapeutics plc - American Depositary Shares  (ADAP) 
Last adaptimmune therapeutics plc - american depositary shares earnings: 5/9 07:30 am Check Earnings Report
PDF Net Loss: Reduced to $47.9 million in Q4 2023 from $29.3 million in Q4 2022; Annual net loss decreased to $113.9 million from $165.5 million year-over-year. Revenue: [Read more]